Mushfiquddin Khan Selected Research

Immunomodulation

1/2021

Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mushfiquddin Khan Research Topics

Disease

13	Stroke (Strokes) 01/2020 - 05/2004
12	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 06/2004
10	Brain Ischemia (Cerebral Ischemia) 01/2020 - 05/2003
10	Inflammation (Inflammations) 08/2015 - 05/2004
8	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2015 - 12/2003
6	Infarction (Infarctions) 01/2020 - 05/2003
6	Ischemia 01/2020 - 05/2003
6	Body Weight (Weight, Body) 12/2019 - 08/2006
6	Demyelinating Diseases (Demyelinating Disease) 03/2013 - 06/2004
4	Neuroinflammatory Diseases 01/2022 - 06/2004
4	Contusions 01/2022 - 08/2015
4	Pain (Aches) 01/2022 - 03/2013
4	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2021 - 10/2004
4	Multiple Sclerosis 11/2021 - 09/2005
4	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2017 - 11/2009
3	Metabolic Diseases (Metabolic Disease) 04/2013 - 01/2009
2	Hypoxia (Hypoxemia) 01/2021 - 05/2017
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2021
2	Cognitive Dysfunction 01/2020 - 08/2008
2	Brain Injuries (Brain Injury) 01/2019 - 11/2009
2	Wounds and Injuries (Trauma) 07/2015 - 11/2009
2	Transient Ischemic Attack 01/2015 - 01/2012
2	Edema (Dropsy) 11/2012 - 07/2011
2	Globoid Cell Leukodystrophy (Krabbe Disease) 06/2008 - 06/2005
2	Alzheimer Disease (Alzheimer's Disease) 05/2008 - 08/2004
2	Ischemic Stroke 07/2007 - 09/2006
2	Reperfusion Injury 05/2004 - 05/2003
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Brain Infarction 01/2020
1	Amyloidosis 01/2020
1	Atrophy 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Sepsis (Septicemia) 10/2016
1	Pathologic Constriction (Stenosis) 05/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015

Drug/Important Bio-Agent (IBA)

16	S-NitrosoglutathioneIBA 01/2021 - 02/2005
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 06/2004
6	Peroxynitrous Acid (Peroxynitrite)IBA 01/2020 - 07/2011
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2008
5	Pharmaceutical PreparationsIBA 01/2020 - 07/2007
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2013 - 12/2003
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2009 - 05/2003
4	N6022IBA 01/2021 - 12/2019
4	CytokinesIBA 01/2021 - 08/2004
4	Glutathione (Reduced Glutathione)IBA 01/2015 - 05/2003
4	AntioxidantsIBA 07/2007 - 05/2003
3	AldehydesIBA 01/2022 - 07/2011
3	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 12/2019
3	LipopolysaccharidesIBA 10/2016 - 02/2004
3	LipidsIBA 05/2015 - 09/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 09/2012
3	Lovastatin (Mevacor)FDA LinkGeneric 08/2008 - 10/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 10/2004
2	Membrane LipidsIBA 01/2022 - 08/2009
2	EnzymesIBA 01/2022 - 01/2020
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 08/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2020 - 02/2005
2	LeukotrienesIBA 05/2015 - 05/2006
2	caffeic acid phenethyl esterIBA 04/2013 - 07/2007
2	salicylhydroxamic acid (SHAM)IBA 03/2013 - 07/2011
2	Simvastatin (Zocor)FDA LinkGeneric 03/2013 - 04/2010
2	Histone Deacetylase InhibitorsIBA 01/2013 - 11/2011
2	Nerve Growth Factors (Neurotrophins)IBA 01/2012 - 07/2011
2	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 11/2011 - 01/2009
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 07/2010 - 05/2006
2	Secretory Phospholipases A2IBA 08/2009 - 06/2008
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2008 - 07/2007
2	Psychosine (Galactosylsphingosine)IBA 06/2008 - 06/2005
2	Amyloid beta-PeptidesIBA 05/2008 - 08/2004
2	NF-kappa B (NF-kB)IBA 07/2007 - 05/2006
2	Free RadicalsIBA 06/2005 - 05/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2004 - 05/2003
2	Interferon-gamma (Interferon, gamma)IBA 06/2004 - 02/2004
1	N- (1,3- benzodioxol- 5- ylmethyl)- 2,6- dichlorobenzamideIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	Pertussis ToxinIBA 11/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 11/2021
1	Mitochondrial Aldehyde DehydrogenaseIBA 01/2021
1	glutathione-independent formaldehyde dehydrogenase (formaldehyde dehydrogenase)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 12/2019
1	CalpainIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2016
1	Caspase 3 (Caspase-3)IBA 10/2016
1	CalciumIBA 07/2015
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 07/2015
1	Phospholipases A2 (Phospholipase A2)IBA 05/2015
1	Dinoprostone (PGE2)FDA Link 05/2015
1	Nonesterified Fatty Acids (NEFA)IBA 05/2015
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 05/2015
1	Protein Isoforms (Isoforms)IBA 05/2015
1	Leukotriene B4IBA 05/2015

Therapy/Procedure

14	Therapeutics 01/2021 - 12/2003
1	Immunomodulation 01/2021
1	Oral Administration 08/2015